A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514413-36-00

Acronym

BS-03

Enrollment

Registered

2024-08-12

Start date

2024-04-29

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of human papilloma virus (HPV) associated infections and cancers

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026